Kyriazi D, Voth L, Bader A, Ewert W, Gerlach J, Elfrink K
Nat Commun. 2024; 15(1):9947.
PMID: 39550360
PMC: 11569205.
DOI: 10.1038/s41467-024-54181-6.
Henson J, Reyes G, Lo N, Herrera K, McKim Q, Herzon H
Front Cell Dev Biol. 2024; 12:1483345.
PMID: 39398481
PMC: 11467475.
DOI: 10.3389/fcell.2024.1483345.
Feroz W, Park B, Siripurapu M, Ntim N, Kilroy M, Sheikh A
Int J Mol Sci. 2024; 25(17).
PMID: 39273383
PMC: 11395477.
DOI: 10.3390/ijms25179435.
Jia W, Czabanka M, Broggini T
Clin Exp Metastasis. 2024; 41(6):817-828.
PMID: 39222238
PMC: 11607095.
DOI: 10.1007/s10585-024-10308-z.
Hartman J, Hwee D, Robert-Paganin J, Chuang C, Chin E, Edell S
Nat Cardiovasc Res. 2024; 3(8):1003-1016.
PMID: 39196032
PMC: 11358156.
DOI: 10.1038/s44161-024-00505-0.
Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8 T cells.
Barnkob M, Michaels Y, Andre V, Macklin P, Gileadi U, Valvo S
Nat Commun. 2024; 15(1):3173.
PMID: 38609390
PMC: 11017241.
DOI: 10.1038/s41467-024-47424-z.
DNA-functionalized artificial mechanoreceptor for de novo force-responsive signaling.
Yang S, Wang M, Tian D, Zhang X, Cui K, Lu S
Nat Chem Biol. 2024; 20(8):1066-1077.
PMID: 38448735
DOI: 10.1038/s41589-024-01572-x.
Contractility defects hinder glycoprotein VI-mediated platelet activation and affect platelet functions beyond clot contraction.
Kenny M, Pollitt A, Patil S, Hiebner D, Smolenski A, Lakic N
Res Pract Thromb Haemost. 2024; 8(1):102322.
PMID: 38379711
PMC: 10877441.
DOI: 10.1016/j.rpth.2024.102322.
Toward physics-based precision medicine: Exploiting protein dynamics to design new therapeutics and interpret variants.
Meller A, Kelly D, Smith L, Bowman G
Protein Sci. 2024; 33(3):e4902.
PMID: 38358129
PMC: 10868452.
DOI: 10.1002/pro.4902.
Dissolution of spiral wave's core using cardiac optogenetics.
Hussaini S, Ladke S, Schroder-Schetelig J, Venkatesan V, Quinonez Uribe R, Richter C
PLoS Comput Biol. 2023; 19(12):e1011660.
PMID: 38060618
PMC: 10729946.
DOI: 10.1371/journal.pcbi.1011660.
From amino-acid to disease: the effects of oxidation on actin-myosin interactions in muscle.
Elkrief D, Matusovsky O, Cheng Y, Rassier D
J Muscle Res Cell Motil. 2023; 44(4):225-254.
PMID: 37805961
DOI: 10.1007/s10974-023-09658-0.
Mechanism of small molecule inhibition of Plasmodium falciparum myosin A informs antimalarial drug design.
Moussaoui D, Robblee J, Robert-Paganin J, Auguin D, Fisher F, Fagnant P
Nat Commun. 2023; 14(1):3463.
PMID: 37308472
PMC: 10261046.
DOI: 10.1038/s41467-023-38976-7.
HTS driven by fluorescence lifetime detection of FRET identifies activators and inhibitors of cardiac myosin.
Muretta J, Rajasekaran D, Blat Y, Little S, Myers M, Nair C
SLAS Discov. 2023; 28(5):223-232.
PMID: 37307989
PMC: 10422832.
DOI: 10.1016/j.slasd.2023.06.001.
Small molecule drugs to improve sarcomere function in those with acquired and inherited myopathies.
Claassen W, Baelde R, Galli R, de Winter J, Ottenheijm C
Am J Physiol Cell Physiol. 2023; 325(1):C60-C68.
PMID: 37212548
PMC: 10281779.
DOI: 10.1152/ajpcell.00047.2023.
HER2 inhibition increases non-muscle myosin IIA to promote tumorigenesis in HER2+ breast cancers.
Alanazi S, Feroz W, Mishra R, Kilroy M, Patel H, Yuan L
PLoS One. 2023; 18(5):e0285251.
PMID: 37200287
PMC: 10194889.
DOI: 10.1371/journal.pone.0285251.
MyosinA is a druggable target in the widespread protozoan parasite Toxoplasma gondii.
Kelsen A, Kent R, Snyder A, Wehri E, Bishop S, Stadler R
PLoS Biol. 2023; 21(5):e3002110.
PMID: 37155705
PMC: 10185354.
DOI: 10.1371/journal.pbio.3002110.
Fine-Tuning Regulation of Surface Mobility by Acrylate Copolymers and Its Effect on Cell Adhesion and Differentiation.
Morata-Martinez M, Sprott M, Antolinos-Turpin C, Salmeron-Sanchez M, Gallego-Ferrer G
ACS Appl Bio Mater. 2023; 6(5):1755-1762.
PMID: 37067245
PMC: 10189726.
DOI: 10.1021/acsabm.2c01053.
Predicting allosteric sites using fast conformational sampling as guided by coarse-grained normal modes.
Zheng W
J Chem Phys. 2023; 158(12):124127.
PMID: 37003737
PMC: 10066797.
DOI: 10.1063/5.0141630.
Drug specificity and affinity are encoded in the probability of cryptic pocket opening in myosin motor domains.
Meller A, Lotthammer J, Smith L, Novak B, Lee L, Kuhn C
Elife. 2023; 12.
PMID: 36705568
PMC: 9995120.
DOI: 10.7554/eLife.83602.
Isoform selectivities of novel 4-hydroxycoumarin imines as inhibitors of myosin II.
Smith J, Brawley J, Bordenave K, Olsen R, Intasiri A, Cremo C
Eur J Med Chem. 2022; 247:115008.
PMID: 36543032
PMC: 9889102.
DOI: 10.1016/j.ejmech.2022.115008.